Literature DB >> 2232886

P190 BCR/ABL transcript in a case of Philadelphia-positive multiple myeloma.

P Martiat1, C Mecucci, Y Nizet, M Stul, M Philippe, J J Cassiman, J L Michaux, H Van den Berghe, G Sokal.   

Abstract

Philadelphia positive multiple myeloma is a very rare event and, so far, no molecular data about the involvement of the BCR and C-ABL genes are available. We report here the case of a 64-year-old woman presenting with a typical multiple myeloma and a complex Philadelphia (Ph) chromosome that we investigated at a molecular level using conventional DNA techniques and the polymerase chain reaction (PCR). No rearrangement was observed within the major breakpoint cluster region (M-BCR) although she was found to have a P190 BCR/ABL hybrid transcript using PCR. As far as we know, this is the first description of a P190-type mRNA in a patient with a chronic lymphoid disorder. Since P190 is almost always associated in man with acute forms of hematological malignancies, this suggests that other factors may play a role in determining the phenotype of the disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2232886

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript.

Authors:  A Tchirkov; J-L Couderc; B Périssel; C Goumy; A Regnier; N Uhrhammer; P Verrelle; M Berger
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

2.  Reply to MacLeod et al.: Multiple myeloma plasma cells have chameleon characteristics.

Authors:  Susanne B Breitkopf; Min Yuan; German A Pihan; John M Asara
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

3.  Triomics Analysis of Imatinib-Treated Myeloma Cells Connects Kinase Inhibition to RNA Processing and Decreased Lipid Biosynthesis.

Authors:  Susanne B Breitkopf; Min Yuan; Katja P Helenius; Costas A Lyssiotis; John M Asara
Journal:  Anal Chem       Date:  2015-10-12       Impact factor: 6.986

4.  Detection of a rare BCR-ABL tyrosine kinase fusion protein in H929 multiple myeloma cells using immunoprecipitation (IP)-tandem mass spectrometry (MS/MS).

Authors:  Susanne B Breitkopf; Min Yuan; German A Pihan; John M Asara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

5.  A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib.

Authors:  Samer Alsidawi; Abhimanyu Ghose; Julianne Qualtieri; Neetu Radhakrishnan
Journal:  Case Rep Oncol Med       Date:  2014-12-02

6.  Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantation.

Authors:  Onyee Chan; Abdur Rehman Jamil; Rebecca Millius; Ramandeep Kaur; Faiz Anwer
Journal:  Clin Case Rep       Date:  2017-02-26

Review 7.  Therapeutic Cancer Vaccines-Antigen Discovery and Adjuvant Delivery Platforms.

Authors:  Neftali Ortega Alarcon; Maddy Jaramillo; Heidi M Mansour; Bo Sun
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.